The Untold Truth: Potency and Risks of Today's Marijuana with Dr. Raymond Wiggins

Dr. Raymond Wiggins is a licensed physician with nearly three decades of experience in healthcare. He has played various leadership roles and has expertly administered general anesthetics to over 27,000 patients, including numerous marijuana users. Dr. Wiggins is also the author of the book series "Weeding Out the Myths About Marijuana," which delves into the misconceptions and scientific insights surrounding marijuana consumption. He initially pursued a business degree but later transitioned to a medical career, establishing a successful practice as an oral and maxillofacial surgeon. Please learn more about Dr. Raymond Wiggins at www.DrWiggins.com In this compelling episode of Mr. Biz Radio, Ken "Mr. Biz" Wentworth rewelcomes Dr. Raymond Wiggins for an in-depth discussion on the Weeding Out the Myths About Marijuana book series. Together, they examine marijuana's evolving potency, debunk common misconceptions, and explore both scientific research and personal insights from Dr. Wiggins’ medical practice. The conversation highlights the rise in THC levels, the potential long-term health risks, including cognitive and cardiovascular effects, and the broader economic and societal impacts of marijuana legalization. Key Takeaways: -The potency of marijuana has increased significantly over the decades, with today's THC levels ten times higher than during the Woodstock era. -Long-term marijuana use can lead to serious health issues, including heart, lung, and cognitive damage, impacting IQ and increasing risks of various ailments. -Increased medical and psychiatric ER visits are linked to marijuana ingestion, particularly from edibles due to delayed effects. -There are substantial economic and societal impacts of marijuana legalization, including higher healthcare costs, more frequent car accidents, and workplace productivity issues. -Medical marijuana does not clinically support the purported therapeutic benefits like pain or anxiety relief, often serving more as a placebo.